Zsolt Bosnyak
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study.
Journal: Diabetes, obesity & metabolism
Published: December 11, 2020
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial.
Journal: Diabetes, obesity & metabolism
Published: October 27, 2020
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: June 25, 2020
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: May 04, 2020
The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM.
Journal: Diabetes/metabolism research and reviews
Published: April 07, 2020
Nearly a Century of Insulin at Sanofi: Looking Back Over the Decades of Production and Development.
Journal: Pediatric endocrinology reviews : PER
Published: March 26, 2020
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C-peptide levels in insulin-naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial.
Journal: Diabetes, obesity & metabolism
Published: February 16, 2020
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus.
Journal: Current medical research and opinion
Published: December 24, 2019
Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial.
Journal: Diabetes, obesity & metabolism
Published: December 18, 2019
InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 06, 2019
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study.
Journal: Diabetes, obesity & metabolism
Published: July 15, 2019
Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real-world study.
Journal: Diabetes, obesity & metabolism
Published: March 26, 2019
Last Updated: 09/26/2026